Showing results (191-200 of 210) with videos related to
Sort By:
Pageof 21
European Heart Journal|December 1, 2001
Incidence and predictors of bleeding events after fibrinolytic therapy with fibrin-specific agents: a comparison of TNK-tPA and rt-PAF Van de Werf, H V Barron, P W Armstrong, et al.Circulation|March 7, 1998
Non-Q-wave versus Q-wave myocardial infarction after thrombolytic therapy: angiographic and prognostic insights from the global utilization of streptokinase and tissue plasminogen activator for occluded coronary arteries-I angiographic substudy. GUSTO-I Angiographic InvestigatorsS G Goodman, A Langer, A M Ross, et al.Journal of Internal Medicine|September 30, 2017
Psychosocial stress and major cardiovascular events in patients with stable coronary heart diseaseE Hagström, F Norlund, A Stebbins, et al.The American Journal of Cardiology|May 30, 1998
Higher T-wave amplitude associated with better prognosis in patients receiving thrombolytic therapy for acute myocardial infarction (a GUSTO-I substudy). Global Utilization of Streptokinase and Tissue plasminogen Activator for Occluded Coronary ArteriesJ Hochrein, F Sun, K S Pieper, et al.Circulation|June 20, 2001
Benefit of glycoprotein IIb/IIIa inhibition in patients with acute coronary syndromes and troponin t-positive status: the paragon-B troponin T substudyL K Newby, E M Ohman, R H Christenson, et al.Circulation|August 16, 2000
Dose-finding, safety, and tolerability study of an oral platelet glycoprotein IIb/IIIa inhibitor, lotrafiban, in patients with coronary or cerebral atherosclerotic diseaseR A Harrington, P W Armstrong, C Graffagnino, et al.Circulation|November 3, 1998
Value of serial troponin T measures for early and late risk stratification in patients with acute coronary syndromes. The GUSTO-IIa InvestigatorsL K Newby, R H Christenson, E M Ohman, et al.Journal of the American College of Cardiology|July 14, 2001
Prognostic value of ST segment depression in acute coronary syndromes: insights from PARAGON-A applied to GUSTO-IIb. PARAGON-A and GUSTO IIb Investigators. Platelet IIb/IIIa Antagonism for the Reduction of Acute Global Organization NetworkP Kaul, Y Fu, W C Chang, et al.The New England Journal of Medicine|October 31, 1996
Cardiac troponin T levels for risk stratification in acute myocardial ischemia. GUSTO IIA InvestigatorsE M Ohman, P W Armstrong, R H Christenson, et al.The American Journal of Cardiology|June 27, 2000
Use of resources, quality of life, and clinical outcomes in patients with and without new Q waves after thrombolytic therapy for acute myocardial infarction (from the GUSTO-I trial)A Barbagelata, R M Califf, E B Sgarbossa, et al.Pageof 21